SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ArQule
ARQL 20.000.0%Jan 16 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jay silberman who wrote (37)2/1/1997 11:32:00 PM
From: scaram(o)uche   of 399
 
This is why they went up, and they're great competition. Good company.
PCOP BT01/3107:32


Pharmacopeia 4Q Losses 19c A Share Vs 60c

Year Dec. 31:
1996 1995
Revenues $14,799,000 $5,151,000
Net income (8,383,000) (8,956,000)
Avg shrs 10,833,980 2,231,102
Shr earns
Net income (.77) (2.77)




Figures in parentheses are losses.

Pharmacopeia Inc. (PCOP) said its losses reflect continuing
investments in its core technology and growing investments in
proprietary drug discovery programs.

Pharmacopeia is a drug discovery company.

Pharmacopeia Inc. - Princeton, N.J.
4th Quar Dec. 31:
1996 1995
Revenues $5,293,000 $1,503,000
Net income (2,081,000) (2,901,000)
Avg shrs 11,022,071 4,873,888
Shr earns
Net income (.19) (.60)




Figures in parentheses are losses.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext